טוען...
Target Therapy in Hematological Malignances: New Monoclonal Antibodies
Apart from radio- and chemotherapy, monoclonal antibodies (MoAbs) represent a new, more selective tool in the treatment of hematological malignancies. MoAbs bind with the specific antigens of the tumors. This interaction is a basis for targeted therapies which exhibit few side effects and significan...
שמור ב:
| הוצא לאור ב: | Int Sch Res Notices |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Hindawi Publishing Corporation
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4897146/ https://ncbi.nlm.nih.gov/pubmed/27433507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/701493 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|